💸 High Impact

Wana Is Locked In Now Its Time To Scale

Canopy Growth Corporation is rolling up its U.S. footprint in a big way. Through its subsidiary, Canopy USA, LLC, the company has completed the acquisition of Wana Brands—including Wana Wellness, The CIMA Group, and Mountain High Products. This move gives Canopy USA full ownership of Wana’s outstanding equity interests, solidifying its position in the burgeoning U.S. cannabis market. Talk about expanding your canopy!

This acquisition follows Canopy USA’s earlier purchase of approximately 75% of Lemurian, Inc., better known as Jetty, back in June 2024. With both Wana and Jetty now under its umbrella, Canopy USA is fast-tracking its strategy to become a leading brand-focused cannabis powerhouse in the United States. The two brands are already sparking up collaborations, like establishing a joint sales force in New York to dominate the edibles and vape segments. Looks like they're not just blowing smoke!

Adding more buzz to the mix, Wana recently launched Wanderous™, a pioneering direct-to-consumer marketplace. Wanderous offers consumers a curated selection of high-quality hemp-derived products, including Delta-9-THC and non-intoxicating CBD gummies from top brands like Cann, Happi, Charlotte’s Web, Martha Stewart CBD, and MXXN. Wana also introduced Wana Beverages—a new line of ready-to-drink infused sparkling beverages that combine hemp extracts with real fruit juice and other beneficial ingredients. It's like happy hour got a herbal upgrade!

David Klein, CEO of Canopy Growth : “With Wana now part of Canopy USA alongside Jetty, we’re gaining momentum while reinforcing our commitment to building a diverse portfolio of industry-leading brands in the U.S. cannabis market. Completing the acquisition of Wana marks another significant milestone in Canopy USA’s strategy and unlocks new growth opportunities across both state-legal markets and through hemp-derived products across the U.S.”

Joe Hodas, President of Wana Brands, chimed in: “This acquisition represents an exciting next step for Canopy USA, as we blend Wana’s expertise in crafting innovative edibles with Jetty’s pioneering developments in vape and extract products. With the launch of Wanderous and the expansion of our core portfolio into new U.S. states, Wana continues its leadership in the North American edibles category with trusted, high-quality product offerings.”

Looking ahead, Canopy USA plans to further expand its portfolio with the anticipated acquisition of Acreage Holdings, Inc. This series of strategic moves is expected to yield significant financial benefits, including revenue growth and cost synergies across Canopy USA’s ecosystem. By consolidating these industry leaders, Canopy is positioning itself to capitalize on the evolving U.S. cannabis landscape, leveraging brand strength and innovative product lines to capture market share.

📈 Dog Walkers

Riv Capital Have Approval From The State of NY

RIV Capital Inc. (CSE: RIV, OTC: CNPOF) and Cansortium Inc. (CSE: TIUM.U, OTCQB: CNTMF) just got the green light from the New York Cannabis Control Board for their business combination. Think of it as a cannabis marriage made in Wall Street heaven. Robert Beasley, CEO of Cansortium, is over the moon, expecting to tie the knot by Q4 2024. With integration already in full swing, they're gearing up to better serve New York's rapidly expanding cannabis market. Post-merger, the combined entity will operate under the Cansortium name, with shares continuing to trade under their current symbols. Investors, keep your eyes peeled—this could be the joint venture that sparks new growth.

Spinach Is King North Of The Border

Looks like Cronos Group Inc. (NASDAQ: CRON) is reaping what they've sown, with their Spinach® brand sprouting to become Canada's top-selling cannabis brand. Since its 2018 debut, Spinach has leafed out to dominate both the edibles and flower markets. CEO Mike Gorenstein sees this as validation of their disruptive product portfolio and hints at more innovations to come. Chief Growth Officer Jeff Jacobson isn't surprised either, crediting their focus on elevating the adult consumer experience. With plans to roll out new products as global regulations loosen, Cronos is positioning Spinach not just as a side dish but the main course in the cannabis industry. Investors might want to take a bite.

Cardiol Raises Capital To Complete Trials

Cardiol Therapeutics Inc. (NASDAQ, TSX: CRDL) just infused its balance sheet with $13.5 million by closing a public offering of 8,437,500 shares at $1.60 a pop. Canaccord Genuity played cupid as the sole bookrunner. The fresh funds are earmarked to propel the clinical development of CardiolRx for treating recurrent pericarditis—because who doesn't appreciate a strong ticker? The offering jumped through all the regulatory hoops, filing paperwork on both sides of the border. Looks like Cardiol is keeping its heartbeat steady.

👾 Number Of The Day

$110,000,000 Amount of Spinach branded product sold in Ontario the last year.

🗞️ The News

Spinach® Is the Number One Cannabis Brand in Canada

RIV Capital and Cansortium Receive New York State Cannabis Control Board Approval for Change of Control

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Nebraska Medical Marijuana Legalization Ballot Initiative Would Create Nearly $1 Billion In Economic Benefits By 2030, Analysis Finds

New Hampshire Lawmakers Fail To Override Governor’s Veto Of Bill To Let Medical Marijuana Be Grown In Greenhouses

Federal Ban On Gun Possession By Marijuana Consumers Challenged In Federal Appeals Court Arguments

📺 YouTube

Behind The Curtain of Village Farms B.C. Cannabis Facility | Trade to Black on Location

What we covered:

✅ Trade To Black premieres a behind-the-scenes documentary film featuring Village Farms (NASDAQ: VFF). Join Shadd and Anthony as they travel west to Vancouver, Canada, to see the company's impressive 2.2 million square foot facility in Delta, British Columbia, known as Pure Sunfarms.

The region is renowned as one of the best natural environments for growing cannabis in the world, which demonstrates that size and scale can actually work in the cannabis industry.

Over 72,000 plants in the grow alone gives you a better understanding as to why VFF’s total sales grew by 21% in 2024, propelling them to the number 2 national market share in the Canadian cannabis landscape.